About: Normobaric hyperoxia reduces the neurovascular complications associated with delayed tissue plasminogen activator treatment in a rat model of focal cerebral ischemia

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Normobaric hyperoxia reduces the neurovascular complications associated with delayed tissue plasminogen activator treatment in a rat model of focal cerebral ischemia Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 28 May 2009

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articolo scientifico (it) artigo científico (pt) bilimsel makale (tr) vedecký článok (sk) vetenskaplig artikel (sv) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научни чланак (sr) article scientifique (fr) artículu científicu espublizáu en 2009 (ast) наукова стаття, опублікована в травні 2009 (uk) scientific article published on 28 May 2009 (en) مقالة علمية نشرت في 28 مايو 2009 (ar)
publication date	wds:Q37271168-858B7F80-376B-4DD8-B507-D8C834934135
publication date	2009-05-28 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q37271168-5DD80A6B-64C6-4427-9AD9-0A114843215F
language of work or name	English
cites work	wds:Q37271168-0503B865-B5FB-4D5D-B370-556C912696DE wds:Q37271168-1639BFFA-BAE8-4064-A3D5-122A0D364F43 wds:Q37271168-16A8E603-061E-4252-914D-9771F508EEB6 wds:Q37271168-1CA8F9CB-419F-459F-9DB1-C856B0F3A55E wds:Q37271168-21BC9668-2AF0-4876-A404-D63863A5180A wds:Q37271168-2B507DD7-BC9B-47E4-8A79-F96B09C0B9E5 wds:Q37271168-2D597045-0B6B-474A-B8C3-D004632A1DA6 wds:Q37271168-45BA9489-77C2-41D7-8E82-9CC308405AEB wds:Q37271168-48649D83-AFA5-4A18-ADA2-D9C8C1B48184 wds:Q37271168-4D8A3F9D-73AF-4A33-B895-2409E34A8615 wds:Q37271168-58FAA06B-3C9C-410B-9CB8-4406E792596B wds:Q37271168-593844E4-75FA-4207-BB9B-521BA20E85BF wds:Q37271168-5A0BB2F8-5D3B-4E37-A2A6-D9C5DACB388E wds:Q37271168-76ED2C92-B1B8-4FFB-A59B-3E0E691D5297 wds:Q37271168-7989A09A-DAE2-44F1-A91A-207273807917 wds:Q37271168-79FA0D3C-2B38-4291-BDAD-84C8099AA907 wds:Q37271168-80ED320D-6CBF-4089-8B55-40155BDB7A67 wds:Q37271168-8210D965-5BF3-49F0-A151-4802D4040FEF wds:Q37271168-84A2A01D-F5A5-4D9E-8377-4E1A0E0316A7 wds:Q37271168-85FC51AA-812D-4F7F-8BF6-4431915936E7 wds:Q37271168-8E60BA4C-8A50-40A1-9171-B0389F940925 wds:Q37271168-99D9D9F1-0278-4A48-BC86-125115DF03F3 wds:Q37271168-9E5839BA-C68E-4AAC-9F9F-E30E0A2D467B wds:Q37271168-A7A7B7DA-9B0B-4143-A7BA-4B20467BBE57 wds:Q37271168-A7DCEA2A-C7A9-4457-A108-81D575A5049C wds:Q37271168-BF0B2143-F663-4CF0-9BCE-7F33CE8B0415 wds:Q37271168-C2B44762-0D0A-491C-87A4-76D789003764 wds:Q37271168-C8256C97-7A3E-471B-B637-FC4CA8CB611B wds:Q37271168-C9AD56A6-02D7-45B3-8F39-2215C3775D96 wds:Q37271168-D2944EBD-A7D5-41EE-975B-F0FB0189A2BE wds:Q37271168-E024E676-5BA1-46EA-8662-8C19A1480967 wds:Q37271168-E2BD707F-32D7-4AB2-9037-F706A003159F wds:Q37271168-E47124C4-456C-4485-B3B2-DACF0610D90F wds:Q37271168-EE8AF891-1FF6-4A9A-AE00-1E5C1CE53673 wds:Q37271168-EF488E16-7205-45A4-ADEF-8680EDE85929
cites work	Tissue plasminogen activator for acute ischemic stroke Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS) Matrix metalloproteinases in cerebrovascular disease Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein. Activated protein C inhibits tissue plasminogen activator-induced brain hemorrhage. Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke. Normobaric hyperoxia improves cerebral blood flow and oxygenation, and inhibits peri-infarct depolarizations in experimental focal ischaemia Normobaric hyperoxia inhibits NADPH oxidase-mediated matrix metalloproteinase-9 induction in cerebral microvessels in experimental stroke Electron paramagnetic resonance-guided normobaric hyperoxia treatment protects the brain by maintaining penumbral oxygenation in a rat model of transient focal cerebral ischemia. Normobaric hyperoxia reduces MRI diffusion abnormalities and infarct size in experimental stroke. Normobaric hyperoxia delays perfusion/diffusion mismatch evolution, reduces infarct volume, and differentially affects neuronal cell death pathways after suture middle cerebral artery occlusion in rats. Normobaric hyperoxia extends the reperfusion window in focal cerebral ischemia. Normobaric hyperoxia and delayed tPA treatment in a rat embolic stroke model Hemorrhagic transformation in acute ischemic stroke. Potential contributing factors in the European Cooperative Acute Stroke Study Plasma metalloproteinase-9 concentration predicts hemorrhagic transformation in acute ischemic stroke Studies on the specific fibrinolytic effect of human extrinsic (tissue-type) plasminogen activator in human blood and in various animal species in vitro Reduction of tissue plasminogen activator-induced matrix metalloproteinase-9 by simvastatin in astrocytes Hemorrhagic transformation and microvascular integrity during focal cerebral ischemia/reperfusion Correlation between motor impairment and infarct volume after permanent and transient middle cerebral artery occlusion in the rat. National US Estimates of Recombinant Tissue Plasminogen Activator Use Extension of the thrombolytic time window with minocycline in experimental stroke. Closure of the blood-brain barrier by matrix metalloproteinase inhibition reduces rtPA-mediated mortality in cerebral ischemia with delayed reperfusion tPA and proteolysis in the neurovascular unit Metalloproteinase inhibition reduces thrombolytic (tissue plasminogen activator)-induced hemorrhage after thromboembolic stroke. Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator. Multitargeted effects of statin-enhanced thrombolytic therapy for stroke with recombinant human tissue-type plasminogen activator in the rat. Plasma cellular-fibronectin concentration predicts hemorrhagic transformation after thrombolytic therapy in acute ischemic stroke. Serine protease inhibitors: novel therapeutic targets for stroke? Hyperbaric oxygen-induced attenuation of hemorrhagic transformation after experimental focal transient cerebral ischemia. Hemorrhagic transformation following ischemic stroke: significance, causes, and relationship to therapy and treatment Hyperacute stroke therapy with tissue plasminogen activator Eubaric hyperoxemia and experimental cerebral infarction Extension of the therapeutic window for recombinant tissue plasminogen activator with argatroban in a rat model of embolic stroke Thrombolytic therapy for ischemic stroke: from clinical trials to clinical practice
author name string	wds:Q37271168-08881053-84BE-4FC6-8195-725894F1CA43 wds:Q37271168-4935D631-6CD3-4A83-ADB0-C1CDF360F05C wds:Q37271168-770B59FD-161F-42BD-95AC-3896F5725D1E wds:Q37271168-F9EB80A6-C85C-45D1-8CA1-4BA6D9F77163
author name string	Ke Jian Liu Wenlan Liu Jill Hendren Xu-Jun Qin
rdfs:label	Normobaric hyperoxia reduces the neurovascular complications associated with delayed tissue plasminogen activator treatment in a rat model of focal cerebral ischemia (en)

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software